166 related articles for article (PubMed ID: 22791222)
1. Angioimmunoblastic T cell lymphoma in an ankylosing spondylitis patient treated with etanercept.
Jung KH; Lim MJ; Kwon SR; Joo KW; Yi HG; Choi SJ; Park W
Mod Rheumatol; 2013 Jul; 23(4):817-22. PubMed ID: 22791222
[TBL] [Abstract][Full Text] [Related]
2. Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma.
Xu L
BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679193
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
Aksu K; Donmez A; Ertan Y; Keser G; Inal V; Oder G; Tombuloglu M; Kabasakal Y; Doganavsargil E
Rheumatol Int; 2007 Dec; 28(2):185-7. PubMed ID: 17622534
[TBL] [Abstract][Full Text] [Related]
4. Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.
Yachoui R; Farooq N; Amos JV; Shaw GR
Clin Med Res; 2016 Dec; 14(3-4):159-162. PubMed ID: 28188140
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review.
Tsochatzis E; Vassilopoulos D; Deutsch M; Filiotou A; Tasidou A; Archimandritis AJ
J Clin Rheumatol; 2005 Dec; 11(6):326-8. PubMed ID: 16371804
[TBL] [Abstract][Full Text] [Related]
6. Angioimmunoblastic T-cell lymphoma with coexisting plasma cell myeloma: a case report and review of the literature.
Xu J; Tang Y; Zhao S; Zhang W; Xiu Y; Liu T; Wu Y
Tohoku J Exp Med; 2015 Apr; 235(4):283-8. PubMed ID: 25816919
[TBL] [Abstract][Full Text] [Related]
7. Etanercept: new indication. For ankylosing spondylitis: another option.
Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
[TBL] [Abstract][Full Text] [Related]
8. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
Huang J; Zhang PH; Gao YH; Qiu LG
Diagn Cytopathol; 2012 Apr; 40(4):346-51. PubMed ID: 21472868
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
Aksu K; Cagirgan S; Ozsan N; Keser G; Sahin F
Rheumatol Int; 2011 Dec; 31(12):1645-7. PubMed ID: 20013270
[TBL] [Abstract][Full Text] [Related]
10. Membranous glomerulonephritis with the use of etanercept in ankylosing spondylitis.
Kaushik P; Rahmani M; Ellison W
Ann Pharmacother; 2011 Dec; 45(12):e62. PubMed ID: 22116994
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action.
Haraoui B; Krelenbaum M
Semin Arthritis Rheum; 2009 Dec; 39(3):176-81. PubMed ID: 18706681
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
14. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
16. Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review.
Wang Y; Pan Z
Altern Ther Health Med; 2023 Nov; 29(8):733-737. PubMed ID: 37708543
[TBL] [Abstract][Full Text] [Related]
17. Successful etanercept therapy for refractory sacroiliitis in a patient with ankylosing spondylitis and mixed connective tissue disease.
Lee JY; Chang HK; Kim SK
Yonsei Med J; 2008 Feb; 49(1):159-62. PubMed ID: 18306484
[TBL] [Abstract][Full Text] [Related]
18. Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans.
Miladi A; Thomas BC; Beasley K; Meyerle J
Cutis; 2015 Feb; 95(2):113-5. PubMed ID: 25750965
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman JD; Sack KE; Davis JC
N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
